Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2025-12-25 @ 4:48 AM
NCT ID:
NCT03608618
Eligibility Criteria:
Inclusion Criteria:
* Be able to undergo peripheral blood leukapheresis; have successful placement of an intraperitoneal catheter
* Be diagnosed with one of the following: metastatic or unresectable high grade serous adenocarcinoma involving the ovary, primary peritoneum, or fallopian tube with peritoneal involvement, not including mixed histologies, OR unresectable epithelioid or biphasic peritoneal mesothelioma
* Be at least 4 weeks from previous anti-cancer therapy
* Have a life expectancy of greater than 3 months.
Exclusion Criteria:
* Females who are pregnant, trying to become pregnant, or breastfeeding
* Diagnosis of HIV or chronic active Hepatitis B or C
* Symptomatic or uncontrolled brain metastases requiring current treatment
* Impaired cardiac function or clinically significant cardiac disease
* Lack of recovery of prior mild adverse events due to earlier therapies
* Active infection
* Another previous or current malignancy within the last 3 years, with exceptions
* Concomitant chronic use of steroids or NSAIDs
* Concomitant use of complementary or alternative medication or therapy
* Autoimmune disease or inflammatory disease within previous 5 years
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03608618
Study Brief:
Protocol Section:
NCT03608618